Please Wait...

Beatriz Lega

Main profile

Beatriz L. Lega, M.D.
Medical Oncologist

Dr. Lega received her MD degree from the Medical School of the National University of Cordoba, Argentina. She completed her internship and residency in Internal Medicine at Mountainside Hospital and at UMDNJ-Rutgers Medical School (now Robert Wood Johnson) and completed her fellowships in Oncology and Hematology at Rhode Island Hospital (Brown University) and Rutgers Medical School. She teaches at both the Drexel University College of Medicine and the Robert Wood Johnson Medical School where she is a Clinical Professor of Internal Medicine.

Prior to joining BioClinica (formerly CoreLab Partners) in 2007, Dr. Lega has been in practice in the Hematology-Oncology Department at Saint Peter’s University Hospital and the Garden State Medical Group/HIP of New Jersey where she developed an out-patient chemotherapy treatment and transfusion unit and became chief of the Internal Medicine and Oncology Divisions. Dr. Lega was also on staff at the Oncology unit at Rhode Island Medical Center. For many years she served as a member in the Cancer Committees at Robert Wood Johnson University Hospital and at Saint Peter’s University Hospital, where she was Tumor Board Moderator and Chair of the Cancer Committee.
 
Dr. Lega is board certified in Internal Medicine, Medical Oncology and Hematology, and a member of the American Society of Clinical Oncology and the American Society of Hematology.
 
With more than 20 years of clinical practice in Medical Oncology, Dr. Lega main research and clinical interests has been the prevention and treatment of breast cancer. She has been an investigator for many years in NSABP clinical trials and has participated in CALGB, ECOG and multiple industry-sponsored clinical trials and is registered with the National Cancer Institute as an independent investigator. She has presented on prostate cancer and written on bladder involvement in metastatic breast cancer.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

ASCPT 2018 Annual Meeting https://t.co/i0mjYbBq5N Join @Bioclinica Research's Open House 3/22 https://t.co/citlLotbD7
bioclinica (Yesterday)
Heading to DC for DIA's #Pharmacovigilance & Risk Mgmt Strategies Conf.? Visit @Bioclinica in booth 32. Preview our… https://t.co/alU1sCg04l
bioclinica (Yesterday)
Kevin Bishop, named a 'Top Innovator' in #clinicaltrials by @CenterWatch See how we're reducing risk to the clinic… https://t.co/rXBGvIh9Wr
bioclinica (2 days ago)
RT @CenterWatch: Congratulations to all our #2018TopInovators! Read about the innovations in the #CWMonthly special edition, https://t.co/Y…
bioclinica (1 week ago)
RT @CenterWatch: .@Pfizer demonstrates leadership in #clinicaltrial innovation with two spots on the @CenterWatch #2018TopInnovators, https…
bioclinica (1 week ago)
RT @jheanne: I just contributed towards 'Joby' on https://t.co/EHt69JFLZ9 Best wishes to Joby and all our @Bioclinica team members! @Oxfam…
bioclinica (1 week ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen